TTRX Company Profile and Key Details
NASDAQ : TTRX
Turn Therapeutics
$3.41
0.07+2.10%
At Close 4:00 PMPrice Chart
Stock Price Today
Turn Therapeutics Inc. (TTRX) stock surged +2.10%, trading at $3.41 on NASDAQ, up from the previous close of $3.34. The stock opened at $3.48, fluctuating between $3.41 and $3.48 in the recent session.
Stock Snapshot
3.34
Prev. Close
100.41M
Market Cap
3.41
Day Low
-26.23
P/E Ratio
-0.13
EPS (TTM)
N/A
Cash Flow per Share
3.48
Open
29.45M
Number of Shares
3.48
Day High
N/A
Free Float in %
N/A
Book Value
3.99K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 25, 2026 | 3.48 | 3.48 | 3.41 | 3.41 | 4.06K |
| Mar 24, 2026 | 3.43 | 3.45 | 3.20 | 3.34 | 20.13K |
| Mar 23, 2026 | 3.43 | 3.44 | 3.39 | 3.42 | 3.6K |
| Mar 20, 2026 | 3.35 | 3.44 | 3.29 | 3.44 | 14.08K |
| Mar 19, 2026 | 3.24 | 3.43 | 3.24 | 3.43 | 27.95K |
| Mar 18, 2026 | 3.62 | 3.66 | 3.48 | 3.48 | 13.95K |
| Mar 17, 2026 | 3.64 | 3.71 | 3.62 | 3.62 | 23.35K |
| Mar 16, 2026 | 3.68 | 3.71 | 3.64 | 3.65 | 9.03K |
| Mar 13, 2026 | 3.71 | 3.71 | 3.60 | 3.61 | 9.76K |
| Mar 12, 2026 | 3.62 | 3.83 | 3.56 | 3.73 | 28.08K |
| Mar 11, 2026 | 3.56 | 3.69 | 3.56 | 3.59 | 6.16K |
| Mar 10, 2026 | 3.41 | 3.57 | 3.41 | 3.50 | 4.61K |
| Mar 09, 2026 | 3.43 | 3.48 | 3.33 | 3.47 | 25.19K |
| Mar 06, 2026 | 3.35 | 3.60 | 3.33 | 3.50 | 13.84K |
| Mar 03, 2026 | 3.53 | 3.82 | 3.40 | 3.43 | 36.26K |
| Mar 02, 2026 | 3.60 | 3.84 | 3.50 | 3.66 | 26.28K |
| Feb 27, 2026 | 3.76 | 3.76 | 3.52 | 3.60 | 9.16K |
| Feb 26, 2026 | 3.80 | 4.01 | 3.53 | 3.84 | 67.05K |
| Feb 25, 2026 | 3.41 | 3.51 | 3.40 | 3.40 | 18.42K |
| Feb 24, 2026 | 3.44 | 3.48 | 3.35 | 3.35 | 6.33K |
Contact Details
About Company
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Company Information
| Employees | 2 |
| Beta | 6.42 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
Stock Peers
REGN
7.78+1.05%
Regeneron Pharmaceuticals, Inc.$749.47ARGX19.55+2.89%
argenx SE$697.05UTHR9.78+1.84%
United Therapeutics Corporation$541.60MDGL16.89+3.80%
Madrigal Pharmaceuticals, Inc.$461.93VRTX6.35+1.42%
Vertex Pharmaceuticals Incorporated$454.97KRTX0.09+0.03%
Karuna Therapeutics, Inc.$329.83ALNY20.65+6.70%
Alnylam Pharmaceuticals, Inc.$328.70PRAX17.27+5.86%
Praxis Precision Medicines, Inc.$311.92KRYS7.86+3.18%
Krystal Biotech, Inc.$254.95SGEN-0.16-0.07%
Seagen Inc.$228.74Company Overview
Turn Therapeutics Inc. (NASDAQ:TTRX) closed at $3.41 USD, gaining $0.07 (2.10%) from the previous close of $3.34. The stock is currently mid-range between its 52-week high and low $2.57 and $26.50. With a market capitalization of about $100.41 million, Turn Therapeutics Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~6.42). Key stats such as the average daily volume over the past year has been around 36.68 thousand shares, volume is running light vs its 52-week average. Headquartered in Westlake Village, CA, Turn Therapeutics Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Bradley E. Burnam, the company employs approximately 2 people and listed since October 08, 2025. Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.
Technical Performance
TTRX has shown mixed momentum, gaining 9.22% over the past week and -8.7% over the past quarter, though year-to-date performance is up 17.26%. Short-term trend indicators are bullishly aligned (SMA20 4.44%, SMA50 -1.79%, SMA200 -7.75%). The stock’s 14-day RSI is 51.7 (neutral), while the ATR of 0.29 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -85.51% below its high and over 49.41% above its low. Average 10-day trading volume of 14.52 thousand shares is below the 3-month average of 35.59 thousand, indicating normal recent market interest.
Dividend & Fair Value
Dividend and splits history remains an important factor for investors monitoring long-term returns.
Earnings & Analyst Outlook
Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $8.00. The high target offers 134.6% upside. The low target suggests 134.6% downside. The mean target is $8.00. This offers 134.6% upside.
Frequently Asked Questions
What is the current Turn Therapeutics Inc. (TTRX) stock price?
Turn Therapeutics Inc. (NASDAQ: TTRX) stock price is $3.41 in the last trading session. During the trading session, TTRX stock reached the peak price of $3.48 while $3.41 was the lowest point it dropped to. The percentage change in TTRX stock occurred in the recent session was 2.1% while the dollar amount for the price change in TTRX stock was $0.07.
TTRX's industry and sector of operation?
The NASDAQ listed TTRX is part of Biotechnology industry that operates in the broader Healthcare sector. Turn Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of TTRX?
No Data
How TTRX did perform over past 52-week?
TTRX's closing price is 32.69% higher than its 52-week low of $2.57 where as its distance from 52-week high of $26.50 is -87.13%.
How many employees does TTRX have?
Number of TTRX employees currently stands at 2.
Link for TTRX official website?
Official Website of TTRX is: https://www.turntherapeutics.com
How do I contact TTRX?
TTRX could be contacted at phone 818 546 4011 and can also be accessed through its website. TTRX operates from 250 N Westlake Blvd, Westlake Village, CA 91362, United States.
How many shares of TTRX are traded daily?
TTRX stock volume for the day was 3.99K shares. The average number of TTRX shares traded daily for last 3 months was 36.68K.
What is the market cap of TTRX currently?
The market value of TTRX currently stands at $100.41M with its latest stock price at $3.41 and 29.45M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep